Rectal cancer chemoradiotherapy adjuvant. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy11

Rectum Anal Canal Pelvis Lymph Nodes Esophagogastric Junction Surgical Stomas Perineum Cell Line, Tumor Larynx Colonic Pouches Glottis

Organisms2

Mice, Nude Mice, Inbred BALB C

Diseases58

Rectal Neoplasms Esophageal Neoplasms Neoplasm Recurrence, Local Adenocarcinoma Carcinoma, Squamous Cell Head and Neck Neoplasms Colonic Neoplasms Lung Neoplasms Colorectal Neoplasms Nasopharyngeal Neoplasms Pelvic Neoplasms Neoplasm Metastasis Neoplasm Invasiveness Carcinoma, Non-Small-Cell Lung Lymphatic Metastasis Pancreatic Neoplasms Carcinoma Stomach Neoplasms Breast Neoplasms Hypopharyngeal Neoplasms Uterine Cervical Neoplasms Radiation Injuries Oropharyngeal Neoplasms Laryngeal Neoplasms Disease Progression Deglutition Disorders Anastomotic Leak Mucositis Neoplasms Anus Neoplasms Prostatic Neoplasms Ovarian Neoplasms Postoperative Complications Urinary Bladder Neoplasms Carcinoma, Small Cell Otorhinolaryngologic Neoplasms Neoplasms, Second Primary Esophagitis Genetic Predisposition to Disease Sigmoid Neoplasms Neoplasms, Squamous Cell Pharyngeal Neoplasms Recurrence Radiation Pneumonitis Liver Neoplasms Stomatitis Neoplasm, Residual Carcinoma, Signet Ring Cell Brain Neoplasms Microsatellite Instability Mouth Neoplasms Voice Disorders Muscle Neoplasms Leukopenia Bone Neoplasms Nose Neoplasms Carcinoma, Adenosquamous Endometrial Neoplasms

Chemicals and Drugs53

Fluorouracil Adjuvants, Immunologic Cisplatin Antimetabolites, Antineoplastic Deoxycytidine Antineoplastic Agents Freund's Adjuvant Organoplatinum Compounds Leucovorin Tegafur Tumor Markers, Biological Carboplatin Paclitaxel Taxoids Adjuvants, Pharmaceutic Radiation-Sensitizing Agents Oxonic Acid Fluorodeoxyglucose F18 Hydroxyurea Antibodies, Monoclonal, Humanized Radiopharmaceuticals Cancer Vaccines Camptothecin Tamoxifen Cyclophosphamide Antibodies, Monoclonal Tumor Suppressor Protein p53 Neoplasm Proteins Uracil Antineoplastic Agents, Hormonal Etoposide Mitomycin Receptors, Estrogen Thymidylate Synthase Antineoplastic Agents, Alkylating Semustine DNA, Neoplasm Vinblastine Receptor, erbB-2 Ki-67 Antigen Antineoplastic Agents, Phytogenic Aluminum Hydroxide Levamisole Receptor, Epidermal Growth Factor Epirubicin Vincristine RNA, Messenger Drug Combinations Methotrexate Dacarbazine Receptors, Progesterone Carcinoembryonic Antigen Doxorubicin

Analytical, Diagnostic and Therapeutic Techniques and Equipment105

Chemoradiotherapy Chemoradiotherapy, Adjuvant Combined Modality Therapy Radiotherapy, Adjuvant Chemotherapy, Adjuvant Neoadjuvant Therapy Neoplasm Staging Digestive System Surgical Procedures Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Radiotherapy Dosage Disease-Free Survival Survival Rate Preoperative Care Survival Analysis Radiotherapy Prognosis Retrospective Studies Esophagectomy Follow-Up Studies Dose Fractionation Kaplan-Meier Estimate Organ Sparing Treatments Prospective Studies Drug Administration Schedule Proctoscopy Induction Chemotherapy Positron-Emission Tomography Lymph Node Excision Colostomy Colectomy Early Detection of Cancer Radiotherapy, Conformal Feasibility Studies Risk Factors Pelvic Exenteration Multivariate Analysis Postoperative Care Endosonography Risk Assessment Remission Induction Predictive Value of Tests Clinical Trials as Topic Brachytherapy Tomography, X-Ray Computed Gastrectomy Radiotherapy, Intensity-Modulated Cohort Studies Anastomosis, Surgical Randomized Controlled Trials as Topic Tumor Burden Registries Patient Selection Radiotherapy, High-Energy Proportional Hazards Models Immunohistochemistry Sensitivity and Specificity Incidence Postoperative Period Laryngectomy Risk Odds Ratio Preoperative Period Dose-Response Relationship, Radiation SEER Program Treatment Failure Laparoscopy Neoplasm Grading Pneumonectomy Salvage Therapy Gene Expression Profiling Multimodal Imaging Biopsy Confidence Intervals Clinical Trials, Phase II as Topic Magnetic Resonance Imaging Radiation Dosage Lymphatic Irradiation Reproducibility of Results Maximum Tolerated Dose Palliative Care Probability Infusions, Intravenous Questionnaires Logistic Models Reverse Transcriptase Polymerase Chain Reaction Chi-Square Distribution Cystectomy Statistics, Nonparametric Colonoscopy Pilot Projects Transplantation, Autologous ROC Curve Conversion to Open Surgery Clinical Trials, Phase III as Topic Case-Control Studies Radiotherapy Planning, Computer-Assisted Proctocolectomy, Restorative Immunoenzyme Techniques Colonic Pouches Bone Marrow Purging Xenograft Model Antitumor Assays Bone Marrow Transplantation Immunization Regression Analysis

Psychiatry and Psychology1

Phenomena and Processes21

Time Factors Gene Expression Regulation, Neoplastic Sensitivity and Specificity Risk Odds Ratio Drug Resistance, Neoplasm Dose-Response Relationship, Radiation Genetic Predisposition to Disease Radiation Tolerance Genotype Radiation Dosage Dose-Response Relationship, Drug Maximum Tolerated Dose Mutation Microsatellite Instability Probability Chi-Square Distribution Defecation Diet DNA Methylation Polymorphism, Genetic

Disciplines and Occupations4

Colorectal Surgery Medical Oncology Immunohistochemistry Radiation Oncology

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life National Cancer Institute (U.S.)

Humanities1

Quality of Life

Information Science8

Survival Rate Radiotherapy, Conformal Radiotherapy, Intensity-Modulated Registries Incidence SEER Program Questionnaires Radiotherapy Planning, Computer-Assisted

Named Groups1

Health Care49

Treatment Outcome Disease-Free Survival Survival Rate Preoperative Care Survival Analysis Retrospective Studies Follow-Up Studies Kaplan-Meier Estimate Prospective Studies Radiation Injuries Feasibility Studies Risk Factors Multivariate Analysis Postoperative Care Risk Assessment Predictive Value of Tests Clinical Trials as Topic Cohort Studies Randomized Controlled Trials as Topic Registries Patient Selection Proportional Hazards Models Sensitivity and Specificity Age Factors Incidence Postoperative Period Risk Odds Ratio Preoperative Period Dose-Response Relationship, Radiation SEER Program Treatment Failure Confidence Intervals Clinical Trials, Phase II as Topic Radiation Dosage Reproducibility of Results Palliative Care Probability Questionnaires Logistic Models Chi-Square Distribution Statistics, Nonparametric Pilot Projects ROC Curve Clinical Trials, Phase III as Topic Case-Control Studies National Cancer Institute (U.S.)Immunization Regression Analysis

Geographicals4

Utah Japan United States Sweden

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Health Care Geographicals

Chemoradiotherapy Rectal Neoplasms Chemoradiotherapy, Adjuvant Combined Modality Therapy Radiotherapy, Adjuvant Chemotherapy, Adjuvant Neoadjuvant Therapy Fluorouracil Neoplasm Staging Digestive System Surgical Procedures Antineoplastic Combined Chemotherapy Protocols Adjuvants, Immunologic Treatment Outcome Esophageal Neoplasms Neoplasm Recurrence, Local Adenocarcinoma Radiotherapy Dosage Cisplatin Carcinoma, Squamous Cell Disease-Free Survival Survival Rate Preoperative Care Survival Analysis Radiotherapy Prognosis Head and Neck Neoplasms Retrospective Studies Rectum Antimetabolites, Antineoplastic Deoxycytidine Esophagectomy Follow-Up Studies Dose Fractionation Colonic Neoplasms Lung Neoplasms Antineoplastic Agents Kaplan-Meier Estimate Freund's Adjuvant Organoplatinum Compounds Leucovorin Organ Sparing Treatments Prospective Studies Colorectal Neoplasms Drug Administration Schedule Nasopharyngeal Neoplasms Pelvic Neoplasms Neoplasm Metastasis Neoplasm Invasiveness Colorectal Surgery Proctoscopy Carcinoma, Non-Small-Cell Lung Lymphatic Metastasis Pancreatic Neoplasms Carcinoma Induction Chemotherapy Anal Canal Stomach Neoplasms Breast Neoplasms Positron-Emission Tomography Tegafur Lymph Node Excision Hypopharyngeal Neoplasms Tumor Markers, Biological Uterine Cervical Neoplasms Colostomy Radiation Injuries Colectomy Carboplatin Time Factors Early Detection of Cancer Radiotherapy, Conformal Paclitaxel Feasibility Studies Taxoids Pelvis Risk Factors Pelvic Exenteration Oropharyngeal Neoplasms Adjuvants, Pharmaceutic Laryngeal Neoplasms Multivariate Analysis Utah Postoperative Care Endosonography Disease Progression Risk Assessment Remission Induction Deglutition Disorders Predictive Value of Tests Clinical Trials as Topic Anastomotic Leak Brachytherapy Mucositis Tomography, X-Ray Computed Gene Expression Regulation, Neoplastic Radiation-Sensitizing Agents Oxonic Acid Neoplasms Gastrectomy Fluorodeoxyglucose F18

No FAQ available that match "rectal cancer chemoradiotherapy adjuvant"